Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

By HospiMedica International staff writers
Posted on 08 Oct 2026

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. More...

Men with persistent clinical risk factors may still require biopsy, yet standard sampling can miss clinically significant disease and lead to additional procedures without resolving the diagnosis. To improve detection in these cases, researchers have evaluated whether targeted biopsy guided by an alternative imaging technique can identify cancers that MRI may overlook.

Researchers at the Nuclear Medicine Unit of IRCCS Azienda Ospedaliero-Universitaria di Bologna evaluated prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT)-targeted biopsy in men with negative or inconclusive MRI findings. The approach uses PET/CT to identify suspicious areas and direct prostate tissue sampling, complementing systematic biopsy, which samples predefined regions of the gland. Multiparametric MRI can miss an estimated 20%–30% of clinically significant prostate cancers in patients with negative or equivocal findings.

In the prospective, single-center FUPERMAN study, 63 men with negative or inconclusive MRI scans underwent gallium-68 PSMA-11 PET/CT followed by PET fusion-guided biopsy. Eleven participants also underwent dynamic total-body PET imaging. Researchers compared targeted and systematic biopsy performance and assessed whether imaging measurements could help predict clinically significant cancer. The study was published in The Journal of Nuclear Medicine in 2026.

PSMA PET/CT was positive in 25 of the 26 men ultimately diagnosed with clinically significant prostate cancer. Targeted biopsy detected clinically significant disease in 37% of participants, compared with 21% using systematic biopsy alone. Combining the two approaches increased the detection rate to 41%. Maximum standardized uptake value (SUVmax) was independently associated with clinically significant disease, while exploratory dynamic imaging showed distinct kinetic patterns in more aggressive lesions, particularly when imaging findings were unclear.

The findings suggest that PSMA PET/CT may help guide biopsy in men who remain at clinical risk despite negative or inconclusive MRI findings. By directing sampling toward the most suspicious areas, the approach could improve cancer detection and risk assessment, although larger studies are needed to confirm its clinical value.

“Our findings suggest that PSMA PET/CT could provide an additional tool for identifying men who remain at risk despite nondiagnostic MRI findings and for directing the biopsy toward the most suspicious area. If confirmed in larger studies, this approach could make the diagnostic pathway more accurate and personalized,” said Andrea Farolfi, M.D., a nuclear medicine physician at the Nuclear Medicine Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Related Links
IRCCS Azienda Ospedaliero-Universitaria di Bologna


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Design-science framework integrating CML and LLM pipelines for supply chain risk evaluation. (Gupta I, Konduru H, Correa S, et al. A causal analytics approach for interpretable supply chain risk and supplier performance evaluation. Supply Chain Analytics, 2026. doi:10.1016/j.sca.2026.100248)

Causal AI Tool Withholds Ovarian Cancer Treatment Recommendations When Evidence Insufficient

Ovarian cancer treatment often requires individualized decisions, particularly when available patient data do not clearly favor one therapeutic approach. However, artificial intelligence (AI) systems may... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.